Entering text into the input field will update the search result below

Genetic Technologies launches COVID-19 risk test through partnership with Infinity Biologix

  • Genetic Technologies (NASDAQ:GENE) announces the launch of its COVID-19 Serious Disease Risk Test ((COVID-19 Risk Test)) in the U.S. through its partnership with Infinity BiologiX.
  • Shares of the company down nearly 5% premarket.
  • Designed to predict disease severity using genetic and clinical

Recommended For You

About GENE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
GENE--
Genetic Technologies Limited